GLCAT14A Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
GLCAT14A antibody; At5g39990 antibody; MYH19.19 antibody; Beta-glucuronosyltransferase GlcAT14A antibody; EC 2.4.1.- antibody; GT14 family glucuronic acid transferase 1 antibody; AtGlcAT14A antibody
Target Names
GLCAT14A
Uniprot No.

Target Background

Function

GLCAT14A is a beta-glucuronosyltransferase involved in the biosynthesis of type II arabinogalactan (AG). It modifies both the beta-1,6-linked galactan and beta-1,3-linked galactan present in type II AG. This enzyme transfers glucuronate to beta-1,6-galactooligosaccharides with degrees of polymerization ranging from 3 to 11. It also transfers glucuronate to beta-1,3-galactooligosaccharides with degrees of polymerization ranging from 5 to 7. The addition of glucuronate at the O6 position may terminate galactose chain extension. GLCAT14A is required for cell elongation during seedling growth.

Gene References Into Functions
  1. Beta-glucuronosyltransferase (AtGlcAT14A) from Arabidopsis thaliana is involved in the biosynthesis of type II arabinogalactan (AG). This enzyme belongs to the Carbohydrate Active Enzyme database glycosyltransferase family 14 (GT14). PMID: 24128328
Database Links

KEGG: ath:AT5G39990

STRING: 3702.AT5G39990.1

UniGene: At.24142

Protein Families
Glycosyltransferase 14 family
Subcellular Location
Golgi apparatus membrane; Single-pass type II membrane protein.

Q&A

Basic Research Questions

What is the primary biochemical function of GLCAT14A in Arabidopsis?

GLCAT14A is a β-glucuronosyltransferase that transfers glucuronic acid (GlcA) to arabinogalactan proteins (AGPs), contributing to their structural and functional properties. AGPs modified by GLCAT14A play roles in calcium binding, cell wall integrity, and developmental processes like seed germination and trichome branching . Methodological Insight: To confirm enzymatic activity:

  • Use CRISPR-Cas9-generated glcat14a mutants

  • Perform monosaccharide composition analysis (e.g., HPAEC-PAD) on AGP extracts

  • Validate via immunoblotting with LM2 antibody targeting β-GlcA epitopes

How is GLCAT14A antibody specificity validated in experimental systems?

Specificity is confirmed through:

  • Comparative immunoblotting of wild-type vs. glcat14a/b/c mutants (reduced LM2 signal in mutants)

  • Co-localization studies with Golgi markers (e.g., STtmd-GFP)

  • Cross-validation with enzymatic activity assays using recombinant proteins

Advanced Research Challenges

How to resolve contradictions between immunoblotting and monosaccharide analysis in glcat14 mutants?

Discrepancies arise due to:

Immunoblotting (LM2)Monosaccharide Analysis
SensitivityDetects epitope accessibilityQuantifies total GlcA content
LimitationsMay miss truncated AGPsCannot distinguish AGP-bound vs. free GlcA
Resolution Strategy:
  • Combine both methods with AGP purification (β-Yariv reagent)

  • Use glcat14a/b/c triple mutants to minimize functional redundancy

  • Include complementation lines to confirm phenotype reversibility

What experimental designs address functional redundancy among GLCAT14 isoforms?

Advanced approaches include:

  • Higher-order mutants: Generate glcat14a/b/c triple mutants to unmask overlapping functions

  • Tissue-specific promoters: Express GLCAT14A-GFP under native promoters to study spatial regulation

  • Substrate profiling: Compare enzyme kinetics of GLCAT14A vs. GLCAT14D/E using synthetic galactan acceptors

How does GLCAT14A-mediated AGP glucuronylation impact calcium homeostasis?

GLCAT14A-deficient AGPs show:

  • 40–60% reduction in calcium binding capacity

  • Delayed seed germination under ABA stress (1 µM ABA reduces germination rate by 35% in glcat14a/b)
    Experimental validation:

  • Perform calcium quantification via SEM/EDX in trichomes

  • Use calcium chelators (e.g., EGTA) in in vitro AGP-calcium binding assays

Methodological Recommendations

What controls are essential for GLCAT14A-related phenotypic assays?

  • Biological: Wild-type (Col-0) + complementation lines

  • Technical:

    • LM2 antibody pre-adsorption with GlcA-containing AGPs

    • Parallel analysis of AGPs from stem, leaf, and silique (tissue-specific effects)

    • Include glcat14d/e mutants to rule out compensatory mechanisms

How to analyze developmental defects in glcat14a mutants?

Standardized protocols:

  • Seed germination: Stratify seeds ≥3 days, score radicle emergence at 24–72h post-ABA treatment

  • Trichome branching: Use SEM imaging + Imaris 3D reconstruction (wild-type = 3.2 branches vs. glcat14a/b = 2.1)

  • Root hair length: Measure ≥50 hairs per genotype using ImageJ with DIC optics

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.